Deardorf Caren — SEC insider filings

SEC reporting owner CIK 1871152. 18 insider filings on record with FilingPulse; latest filed 2026-11-13.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2021-07-08 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Magenta Therapeutics, Inc. (MGTA)Chief Commercial Officer8—1 leg · 6,238 sh · $41,9827
Crinetics Pharmaceuticals, Inc. (CRNX)Director8——19
Alpha Cognition Inc. (ACOG)Director2——2

Insider filings — Deardorf Caren

FiledFormIssuerReported transactionsSource
2026-11-134Alpha Cognition Inc. (ACOG)Grant/award (A): 755 @ $0 · Grant/award (A): 1,020 (derivative) @ $0EDGAR
2026-11-133Alpha Cognition Inc. (ACOG)Holdings only — no transactions reportedEDGAR
2026-09-014Crinetics Pharmaceuticals, Inc. (CRNX)Disposition to issuer (D): 16,300 @ $85 · Disposition to issuer (D): 5,925 @ $85 · Disposition to issuer (D): 35,000 (derivative) @ $65.70 · Disposition to issuer (D): 4,375 (derivative) @ $66.71 · Disposition to issuer (D): 17,500 (derivative) @ $64.68 · Disposition to issuer (D): 12,500 (derivative) @ $40.29 · +2 moreEDGAR
2026-06-224Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 5,925 @ $0 · Grant/award (A): 9,730 (derivative) @ $0EDGAR
2025-06-134Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 6,900 @ $0 · Grant/award (A): 10,350 (derivative) @ $0EDGAR
2024-06-114Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 3,400 @ $0 · Grant/award (A): 12,500 (derivative) @ $0EDGAR
2023-06-214Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 6,000 @ $0 · Grant/award (A): 17,500 (derivative) @ $0EDGAR
2022-12-024Magenta Therapeutics, Inc. (MGTA)Grant/award (A): 3,000 @ $0.94EDGAR
2022-08-014Magenta Therapeutics, Inc. (MGTA)Grant/award (A): 75,000 (derivative) @ $0EDGAR
2022-06-214Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 4,375 (derivative) @ $0EDGAR
2022-06-064Magenta Therapeutics, Inc. (MGTA)Grant/award (A): 3,000 @ $0.99EDGAR
2022-05-194Magenta Therapeutics, Inc. (MGTA)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2022-04-044/ACrinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2022-03-144Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2022-02-174Magenta Therapeutics, Inc. (MGTA)Grant/award (A): 75,000 (derivative) @ $0EDGAR
2021-09-204Magenta Therapeutics, Inc. (MGTA)Sale (S): 6,238 @ $6.73EDGAR
2021-09-164Magenta Therapeutics, Inc. (MGTA)Grant/award (A): 20,000 @ $0EDGAR
2021-07-084Magenta Therapeutics, Inc. (MGTA)Grant/award (A): 200,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1871152 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs